Paul Chuba, MD
Radiation Oncology · Grosse Pointe Woods, MINPI 1255359766
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,253 of the $1,805 with a category attached, or 69.4%. Isoray, Inc accounts for 84.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $910 and has fallen 97.1% since, to $27 in 2024.
Across 34 payments — averaging $53.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Isoray, Inc$2K
- Sanofi$43
- AstraZeneca$43
- Amgen$41
- Boston Scientific$27
- Boehringer Ingelheim$24
- plus $97 from 6 others
What the payments were for
- Travel & lodging$1,25369%
- Food & beverage$54130%
- Education$121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Isoray, Inc | 19 | $1,531 |
| Sanofi | 2 | $43 |
| AstraZeneca | 3 | $43 |
| Amgen | 2 | $41 |
| Boston Scientific | 1 | $27 |
| Boehringer Ingelheim | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Blue Earth Diagnostics | 1 | $18 |
| Spectrum Pharmaceuticals Inc. | 1 | $17 |
| BK Medical Holding Company Inc. | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Brachytherapy Source$1,183
How this compares
$1,805 in reported general payments places this provider in the 75th percentile of 198 radiation oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $1,110 |
| Lidocaine Hcl ViscousLidocaine Hcl | 20 | $372 |
| Tamsulosin Hcl | 30 | $257 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Grosse Pointe Woods
- Frank ViciniPontiac$231K
- Thomas BoikeClarkston$171K
- Farzan SiddiquiDetroit$72K
- Daniel WahlAnn Arbor$42K
- Daniel ChangAnn Arbor$38K
- Shruti JollyAnn Arbor$30K
- Brandon ManciniGrand Rapids$30K
- Alvaro MartinezFarmington Hills$24K
- James KaneAnn Arbor$19K
- M Salim SiddiquiDetroit$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.